Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FLUORINE-18-FLUORODEOXYGLUCOSE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 304 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Burt, BM; Humm, JL; Kooby, DA; Squire, OD; Mastorides, S; Larson, SM; Fong, YM
      Using positron emission tomography with [F-18]FDG to predict tumor behavior in experimental colorectal cancer

      NEOPLASIA
    2. Najjar, F; Hustinx, R; Jerusalem, G; Fillet, G; Rigo, P
      Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    3. Talbot, JN; Haioun, C; Rain, JD; Meignan, M; Wioland, M; Misset, JL; Grahek, D; Kerrou, K; Montravers, F
      [18F]-FDG positron imaging in clinical management of lymphoma patients

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    4. Nerini-Molteni, S; Seregni, E; Crippa, F; Maffioli, L; Botti, C; Bombardieri, E
      Uptake of tritiated thymidine, deoxyglucose and methionine in three lung cancer cell lines: Deoxyglucose uptake mirrors tritiated thymidine uptake

      TUMOR BIOLOGY
    5. Smith, TAD
      The rate-limiting step for tumor [F-18]fluoro-2-deoxy-D-glucose (FDG) incorporation

      NUCLEAR MEDICINE AND BIOLOGY
    6. Buchmann, I; Reske, SN
      Novel imaging techniques in NHL: Clinical results with PET imaging

      ANNALS OF HEMATOLOGY
    7. Jerusalem, G; Beguin, Y; Najjar, F; Hustinx, R; Fassotte, MF; Rigo, P; Fillet, G
      Positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG)for the staging of low-grade non-Hodgkin's lymphoma (NHL)

      ANNALS OF ONCOLOGY
    8. Sasaki, M; Kuwabara, Y; Yoshida, T; Nakagawa, M; Koga, H; Hayashi, K; Kaneko, K; Chen, T; Ichiya, Y; Masuda, K
      Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung

      ANNALS OF NUCLEAR MEDICINE
    9. Koyama, K; Okamura, T; Kawabe, J; Nakata, B; Chung, KHYS; Ochi, H; Yamada, R
      Diagnostic usefulness of FDG PET for pancreatic mass lesions

      ANNALS OF NUCLEAR MEDICINE
    10. Temmerman, OPP; Heyligers, IC; Hoekstra, OS; Comans, EFI; Roos, JC
      Detection of osteomyelitis using (18)FDG and positron emission tomography

      JOURNAL OF ARTHROPLASTY
    11. Jerusalem, G; Beguin, Y; Fassotte, MF; Najjar, F; Paulus, P; Rigo, P; Fillet, G
      Whole-body positron emission tomography using F-18-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease

      HAEMATOLOGICA
    12. Yun, MJ; Kim, WJ; Adam, LE; Alnafisi, N; Herman, C; Alavi, A
      F-18FDG uptake in a patient with psoriatic arthritis imaging correlation with patient symptoms

      CLINICAL NUCLEAR MEDICINE
    13. Zhuang, HM; Pourdehnad, M; Yamamoto, AJ; Rossman, MD; Alavi, A
      Intense F-18 fluorodeoxyglucose uptake caused by Mycobacterium avium intracellulare infection

      CLINICAL NUCLEAR MEDICINE
    14. Franzius, C; Biermann, M; Hulskamp, G; Frosch, M; Roth, J; Sciuk, J; Schober, O
      Therapy monitoring in aspergillosis using F-18FDG positron emission tomography

      CLINICAL NUCLEAR MEDICINE
    15. Lin, EC; Quaife, RA
      FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging

      CLINICAL NUCLEAR MEDICINE
    16. Yuksel, M; Cermik, TF; Karlikaya, C; Salan, A; Cakir, E; Gultekin, A; Berkarda, F
      Monitoring the chemotherapeutic response in primary lung cancer using Tc-99m-MIBI SPET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    17. Kubota, K; Itoh, M; Ozaki, K; Ono, S; Tashiro, M; Yamaguchi, K; Akaizawa, T; Yamada, K; Fukuda, H
      Advantage of delayed whole-body FDG-PET imaging for tumour detection

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    18. Zhao, S; Kuge, Y; Tsukamoto, E; Mochizuki, T; Kato, T; Hikosaka, K; Hosokawa, M; Kohanawa, M; Tamaki, N
      Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    19. Matheja, P; Kuwert, T; Ludemann, P; Weckesser, M; Kellinghaus, C; Schuierer, G; Diehl, B; Ringelstein, EB; Schober, O
      Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    20. Schumacher, T; Brink, I; Mix, M; Reinhardt, R; Herget, G; Digel, W; Henke, M; Moser, E; Nitzsche, E
      FDG-PET imaging for the staging and follow-up of small cell lung cancer

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    21. Dierickx, LO; Lahoutte, T; Deron, P; Caveliers, V; Vanhove, C; Everaert, H; Bossuyt, A
      Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[I-123]iodo-L-alpha-methyltyrosine SPET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    22. Hattori, N; Bengel, FM; Mehilli, J; Odaka, K; Ishii, K; Schwaiger, M; Nekolla, SG
      Global and regional functional measurements with gated FDG PET in comparison with left ventriculography

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    23. Ohtani, T; Kurihara, H; Ishiuchi, S; Saito, N; Oriuchi, N; Inoue, T; Sasaki, T
      Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    24. Paul, AK; Tatsumi, M; Fujino, K; Hashikawa, K; Nishimura, T
      Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    25. Ahmed, AR; Watanabe, H; Aoki, J; Shinozaki, T; Takagishi, K
      Schwannoma of the extremities: the role of PET in preoperative planning

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    26. Moore, FGA; Andermann, F; Richardson, J; Tampieri, D; Giaccone, R
      The role of MRI and nerve root biopsy in the diagnosis of neurosarcoidosis

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    27. Kluge, R; Schmidt, F; Caca, K; Barthel, H; Hesse, S; Georgi, P; Seese, A; Huster, D; Berr, F
      Positron emission tomography with [F-18]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer

      HEPATOLOGY
    28. Lang, O; Bihl, H; Hultenschmidt, B; Sautter-Bihl, ML
      Clinical relevance of positron emission tomography (PET) in treatment control and relapse of Hodgkin's disease

      STRAHLENTHERAPIE UND ONKOLOGIE
    29. van der Hiel, B; Pauwels, EKJ; Stokkel, MPM
      Positron omission tomography with 2-[18F]-fluoro-2-deaxy-D-glucose in oncology Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    30. Stokkel, MPM; Draisma, A; Pauwels, EKJ
      Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology Part IIIb: Therapy response monitoring in colorectal and lung tumours,head and neck cancer, hepatocellular carcinoma and sarcoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    31. Marom, EM; Aloia, TA; Moore, MB; Hara, M; Herndon, JE; Harpole, DH; Goodman, PC; Patz, EF
      Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer

      LUNG CANCER
    32. Buck, AC; Schirrmeister, HH; Guhlmann, CA; Diederichs, CG; Shen, CX; Buchmann, R; Kotzerke, J; Birk, D; Mattfeldt, T; Reske, SN
      Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis:Does in vivo FDG uptake correlate with proliferative activity?

      JOURNAL OF NUCLEAR MEDICINE
    33. Higashi, K; Ueda, Y; Sakuma, T; Seki, H; Oguchi, M; Taniguchi, M; Taki, S; Tonami, H; Katsuda, S; Yamamoto, I
      Comparison of [F-18]FDG PET and Tl-201 SPECT in evaluation of pulmonary nodules

      JOURNAL OF NUCLEAR MEDICINE
    34. Ohta, M; Tokuda, Y; Suzuki, Y; Kubota, M; Makuuchi, H; Tajima, T; Nasu, S; Suzuki, Y; Yasuda, S; Shohtsu, A
      Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with Tc-99(m)-MDP bone scintigraphy

      NUCLEAR MEDICINE COMMUNICATIONS
    35. Lorenzen, J; Buchert, R; Bohuslavizki, KH
      Value of FDG PET in patients with fever of unknown origin

      NUCLEAR MEDICINE COMMUNICATIONS
    36. Zhuang, HM; Cortes-Blanco, A; Pourdehnad, M; Adam, LE; Yamamoto, AJ; Martinez-Lazaro, R; Lee, JH; Loman, JC; Rossman, MD; Alavi, A
      Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?

      NUCLEAR MEDICINE COMMUNICATIONS
    37. Inoue, T; Koyama, K; Oriuchi, N; Alyafei, S; Yuan, Z; Suzuki, H; Takeuchi, K; Tomaru, Y; Tomiyoshi, K; Aoki, J; Endo, K
      Detection of malignant tumors: Whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG - Preliminary study

      RADIOLOGY
    38. Aoki, J; Watanabe, H; Shinozaki, T; Takagishi, K; Ishijima, H; Oya, N; Sato, N; Inoue, T; Endo, K
      FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions

      RADIOLOGY
    39. Hueltenschmidt, B; Sautter, ML; Lang, O; Maul, FD; Fischer, J; Mergenthaler, HG; Bihl, H
      Whole body positron emission tomography in the treatment of Hodgkin disease

      CANCER
    40. Ullerich, H; Franzius, C; Domagk, D; Seidel, M; Sciuk, J; Schober, O; Domschke, W
      F-18-fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: The only sensitive method of imaging

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    41. Di Martino, E; Nowak, B; Krombach, GA; Seilhaus, B; Hausmann, R; Cremerius, U; Bull, U; Westhofen, M
      Results of pretherapeutic lymph node diagnosis in head and neck cancer: Clinical value of (18)-fluorodeoxyglucose positron emission tomography (PET).

      LARYNGO-RHINO-OTOLOGIE
    42. Folpe, AL; Lyles, RH; Sprouse, JT; Conrad, EU; Eary, JF
      (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma

      CLINICAL CANCER RESEARCH
    43. Sundin, A; Eriksson, B; Bergstrom, M; Bjurling, P; Lindner, KJ; Oberg, K; Langstrom, B
      Demonstration of [C-11] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography

      NUCLEAR MEDICINE AND BIOLOGY
    44. Maisey, NR; Hill, ME; Webb, A; Cunningham, D; Flux, GD; Padhani, A; Ott, RJ; Norman, A; Bishop, L
      Are (18)fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

      EUROPEAN JOURNAL OF CANCER
    45. Kobayashi, A; Shinozaki, T; Shinjyo, Y; Kato, K; Oriuchi, N; Watanabe, H; Takagishi, K
      FDG PET in the clinical evaluation of sarcoidosis with bone lesions

      ANNALS OF NUCLEAR MEDICINE
    46. Diederichs, CG; Staib, L; Vogel, J; Glasbrenner, B; Glatting, G; Brambs, HJ; Beger, HG; Reske, SN
      Values and limitations of F-18-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses

      PANCREAS
    47. Gotway, MB; Storto, ML; Golden, JA; Reddy, GP; Webb, WR
      Incidental detection of thoracic sarcoidosis on whole-body (18)fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography

      JOURNAL OF THORACIC IMAGING
    48. Avril, N; Rose, CA; Schelling, M; Dose, J; Kuhn, W; Bense, S; Weber, W; Ziegler, S; Graeff, H; Schwaiger, M
      Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: Use and limitations

      JOURNAL OF CLINICAL ONCOLOGY
    49. Jerusalem, G; Beguin, Y; Fassotte, MF; Najjar, F; Paulus, P; Rigo, P; Fillet, G
      Persistent tumor F-18-FDG uptake after a few cycles of polychemotherapy ispredictive of treatment failure in non-Hodgkin's lymphoma

      HAEMATOLOGICA
    50. Sendler, A; Avril, N; Helmberger, H; Stollfuss, J; Weber, W; Bengel, F; Schwaiger, M; Roder, JD; Siewert, JR
      Preoperative evaluation of pancreatic masses with positron emission tomography using F-18-fluorodeoxyglucose: Diagnostic limitations

      WORLD JOURNAL OF SURGERY
    51. Wong, CO; Bleza, MV; Dworkin, HJ
      The aggressiveness and extent of meningioma imaged by combined fluorine-18FDG and positron emission tomography

      CLINICAL NUCLEAR MEDICINE
    52. Tokita, N; Hasegawa, S; Hirata, M; Yoshioka, J; Yamaguchi, H; Hori, M; Nishimura, T
      Fluorine-18 FDG myocardial positron emission tomographic findings before and after pituitary adenoma resection in a patient with acromegalic cardiomyopathy

      CLINICAL NUCLEAR MEDICINE
    53. Belhocine, TZ; Daenen, F; Duysinx, B; Bury, T; Rigo, P
      Typical appearance of mesothelioma on an F-18FDG positron emission tomograph

      CLINICAL NUCLEAR MEDICINE
    54. Lee, J; Park, CH; Kim, HC; Kim, HS
      Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma

      CLINICAL NUCLEAR MEDICINE
    55. Fujii, H; Yasuda, S; Ide, M; Takahashi, W; Mochizuki, Y; Shohtsu, A; Nakahara, T; Kubo, A
      Increased fluorodeoxyglucose uptake in a calf opposite to a leg with osteosarcoma after operation

      CLINICAL NUCLEAR MEDICINE
    56. Goswami, GK; Jana, S; Santiago, JF; Buyukdereli, G; Salem, SS; Heiba, S; Abdel-Dayem, HM
      Discrepancy between Ga-67 citrate and F-18 fluorodeoxyglucose positron emission tomographic scans in pulmonary infection

      CLINICAL NUCLEAR MEDICINE
    57. Bakheet, SM; Saleem, M; Powe, J; Al Amro, A; Larsson, SG; Mahassin, Z
      F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection

      CLINICAL NUCLEAR MEDICINE
    58. Zhuang, HM; Duarte, PS; Pourdehand, M; Shnier, D; Alavi, A
      Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging

      CLINICAL NUCLEAR MEDICINE
    59. Bakheet, SMB; Powe, J; Kandil, A; Ezzat, A; Rostom, A; Amartey, J
      F-18FDG uptake in breast infection and inflammation

      CLINICAL NUCLEAR MEDICINE
    60. Nakamoto, Y; Higashi, T; Sakahara, H; Tamaki, N; Itoh, K; Imamura, M; Konishi, J
      Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography - Comparison with other modalities

      CLINICAL NUCLEAR MEDICINE
    61. Shreve, PD
      Pseudolymphoma of the lung - Benign pulmonary nodule with elevated fluorodeoxyglucose uptake

      CLINICAL NUCLEAR MEDICINE
    62. Lin, P; Delaney, G; Chu, J; Kiat, H; Pocock, N
      Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis

      CLINICAL NUCLEAR MEDICINE
    63. De Winter, F; Van de Wiele, C; De Clercq, D; Vogelaers, D; De Bondt, P; Dierckx, RA
      Aseptic loosening of a knee prosthesis as imaged on FDG positron emission tomography

      CLINICAL NUCLEAR MEDICINE
    64. Taaleb, K; Kaiser, KP; Wieler, H
      Elevated uptake of F-18FDG in PET scans in nonmalignant disease

      CLINICAL NUCLEAR MEDICINE
    65. Yamaji, S; Ishii, K; Sasaki, M; Mori, T; Kitagaki, H; Sakamoto, S; Mori, E
      Evaluation of standardized uptake value to assess cerebral glucose metabolism

      CLINICAL NUCLEAR MEDICINE
    66. Slavin, JD; Pingle, PR; Spencer, RP; Preskenis, WR
      Incidental detection of a pheochromocytoma on fluorine-18 fluorodeoxyglucose coincidence imaging

      CLINICAL NUCLEAR MEDICINE
    67. Franzius, C; Sciuk, J; Daldrup-Link, HE; Jurgens, H; Schober, O
      FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    68. Hustinx, R; Dolin, RJ; Benard, F; Bhatnagar, A; Chakraborty, D; Smith, RJ; Jang, SY; Alavi, A
      Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    69. Stumpe, KDM; Dazzi, H; Schaffner, A; von Schulthess, GK
      Infection imaging using whole-body FDG-PET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    70. De Sutter, J; De Winter, F; Van de Wiele, C; De Bondt, P; D'Asseler, Y; Dierckx, R
      Cardiac fluorine-18 fluorodeoxyglucose imaging using a dual-head gamma camera with coincidence detection: a clinical pilot study

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    71. Brandt-Mainz, K; Muller, SP; Gorges, R; Saller, B; Bockisch, A
      The value of fluorine-18 fluorodeoxyglucose PET in patients with medullarythyroid cancer

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    72. Kalicke, T; Schmitz, A; Risse, JH; Arens, S; Keller, E; Hansis, M; Schmitt, O; Biersack, HJ; Grunwald, F
      Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results ofhistologically confirmed cases

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    73. Hain, SF; O'Doherty, MJ; Timothy, AR; Leslie, MD; Partridge, SE; Huddart, RA
      Fluorodeoxyglucose PET in the initial staging of germ cell tumours

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    74. Higashi, K; Ueda, Y; Sakurai, A; Wang, XM; Xu, LF; Murakami, M; Seki, H; Oguchi, M; Taki, S; Nambu, Y; Tonami, H; Katsuda, S; Yamamoto, I
      Correlation of Glut-1 glucose transporter expression with [F-18]FDG uptakein non-small cell lung cancer

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    75. Nakamoto, Y; Saga, T; Ishimori, T; Higashi, T; Mamede, M; Okazaki, K; Imamura, M; Sakahara, H; Konishi, J
      FDG-PET of autoimmune-related pancreatitis: preliminary results

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    76. Meller, J; Altenvoerde, G; Munzel, U; Jauho, A; Behe, M; Gratz, S; Luig, H; Becker, W
      Fever of unknown origin: prospective comparison of [F-18]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    77. Watanabe, H; Inoue, T; Shinozaki, T; Yanagawa, T; Ahmed, AR; Tomiyoshi, K; Oriuchi, N; Tokunaga, M; Aoki, J; Endo, K; Takagishi, K
      PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    78. Kostakoglu, L; Goldsmith, SJ
      Fluorine-18 fluorodeoxyglucose positron emission tomography in the stagingand follow-up of lymphoma: is it time to shift gears?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    79. Eigtved, A; Andersson, AP; Dahlstrom, K; Rabol, A; Jensen, M; Holm, S; Sorensen, SS; Drzewiecki, KT; Hojgaard, L; Friberg, L
      Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    80. Mijnhout, GS; Hooft, L; van Tulder, MW; Deville, WLJM; Teule, GJJ; Hoekstra, OS
      How to perform a comprehensive search for FDG-PET literature

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    81. Watanabe, H; Shinozaki, T; Yanagawa, T; Aoki, J; Tokunaga, M; Inoue, T; Endo, K; Mohara, S; Sano, K; Takagishi, K
      Glucose metabolic analysis of musculoskeletal tumours using (18)fluorine-FDG PET as an aid to preoperative planning

      JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
    82. Minn, H; Clavo, AC; Fisher, SJ; Wahl, RL
      Effect of nitroimidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma

      ACTA ONCOLOGICA
    83. Pauwels, EKJ; Sturm, EJC; Bombardieri, E; Cleton, FJ; Stokkel, MPM
      Positron-emission tomography with [F-18]fluorodeoxyglucose Part I. Biochemical uptake mechanism and its implication for clinical studies

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    84. Khan, MA; Combs, CS; Brunt, EM; Lowe, VJ; Wolverson, MK; Solomon, H; Collins, BT; Di Bisceglie, AM
      Positron emission tomography scanning in the evaluation of hepatocellular carcinoma

      JOURNAL OF HEPATOLOGY
    85. Ohira, H; Kubota, K; Ohuchi, N; Harada, Y; Fukuda, H; Satomi, S
      Comparison of intratumoral distribution of Tc-99m-MIBI and deoxyglucose inmouse breast cancer models

      JOURNAL OF NUCLEAR MEDICINE
    86. Yasukawa, T; Yoshikawa, K; Aoyagi, H; Yamamoto, N; Tamura, K; Suzuki, K; Tsujii, H; Murata, H; Sasaki, Y; Fujisawa, T
      Usefulness of PET with C-11-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer

      JOURNAL OF NUCLEAR MEDICINE
    87. Higashi, T; Fisher, SJ; Brown, RS; Nakada, K; Walter, GL; Wahl, RL
      Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: Preclinical PET studies

      JOURNAL OF NUCLEAR MEDICINE
    88. Thie, JA; Hubner, KF; Smith, GT
      The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors

      JOURNAL OF NUCLEAR MEDICINE
    89. Schulte, M; Brecht-Krauss, D; Heymer, B; Guhlmann, A; Hartwig, E; Sarkar, MR; Diederichs, CG; Von Baer, A; Kotzerke, J; Reske, SN
      Grading of tumors and tumorlike lesions of bone: Evaluation by FDG PET

      JOURNAL OF NUCLEAR MEDICINE
    90. Goo, JM; Im, JG; Do, KH; Yeo, JS; Seo, JB; Kim, HY; Chung, JK
      Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases

      RADIOLOGY
    91. Chisin, R; Macapinlac, HA
      The indications of FDG-PET in neck oncology

      RADIOLOGIC CLINICS OF NORTH AMERICA
    92. Pieterman, RM; van Putten, JWG; Meuzelaar, JJ; Mooyaart, EL; Vaalburg, W; Koeter, GH; Fidler, V; Pruim, J; Groen, HJM
      Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

      NEW ENGLAND JOURNAL OF MEDICINE
    93. Blum, J; Handmaker, H; Lister-James, J; Rinne, N
      A multicenter trial with a somatostatin analog Tc-99m depreotide in the evaluation of solitary pulmonary nodules

      CHEST
    94. Maisey, NR; Webb, A; Flux, GD; Padhani, A; Cunningham, DC; Ott, RJ; Norman, A
      FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study

      BRITISH JOURNAL OF CANCER
    95. Brock, CS; Young, H; O'Reilly, SM; Matthews, J; Osman, S; Evans, H; Newlands, ES; Price, PM
      Early evaluation of tumour metabolic response using [F-18]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

      BRITISH JOURNAL OF CANCER
    96. Stahl, A; Weber, WA; Avril, N; Schwaiger, M
      Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    97. Pichler, R; Maschek, W; Hatzl-Griesenhofer, M; Huber, H; Wimmer, G; Wahl, G; Fridrik, M
      Clinical value of FDG hybrid-PET in staging and restaging of malignant lymphoma - compared with conventional diagnostic methods

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    98. Adams, S; Nickel, E; Hor, G
      Differential diagnosis problems in the evaluation of mediastinal and pulmonary lesions with F-18FDG PET

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    99. Zell, L; Hellwig, D; Sommerfeld, A; Ukena, D; Buchter, A; Kirsch, CM
      Silicotic callosity or lung cancer? Problem of functional differentiation by FDG-PET scan

      NUKLEARMEDIZIN
    100. Weidmann, E; Baican, B; Hertel, A; Baum, RP; Chow, KU; Knupp, B; Adams, S; Hor, G; Hoelzer, D; Mitrou, PS
      Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease

      LEUKEMIA & LYMPHOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 07:55:58